Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease

Jason Chia Hsien Cheng, Jian Kuen Wu, Patricia Chiao Tzu Lee, Hua Shan Liu, James Jer Min Jian, Yu Mong Lin, Juei Low Sung, Gwo Jen Jan

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Purpose: To identify the factors associated with radiation-induced liver disease (RILD) and to describe the difference in normal tissue complication probability (NTCP) between subgroups of hepatocellular carcinoma patients undergoing three-dimensional conformal radiotherapy (3D-CRT). Methods and Materials: A total of 89 hepatocellular carcinoma patients who completed 3D-CRT for local hepatic tumors were included. The average isocenter dose was 49.9 ± 6.2 Gy. Logistic regression analysis was used for the association between statistically significant factors and RILD (defined as Grade 3 or 4 hepatic toxicity of elevated transaminases or alkaline phosphatase within 4 months of completing 3D-CRT) in multivariate analysis. Maximal likelihood analysis was conducted to obtain the best estimates of the NTCP model parameters. Results: Of the 89 patients, 17 developed RILD. In univariate analysis, hepatitis B virus (HBV)-positive status and the mean radiation dose to the liver were the two factors significantly associated with the development of RILD. Of the 65 patients who were HBV carriers, 16 had RILD compared with 1 of 24 non-carrier patients (p = 0.03). The mean radiation dose to liver was significantly greater in patients with RILD (22.9 vs. 19.0 Gy, p = 0.05). On multivariate analysis, HBV carrier status (odds ratio, 9.26; p = 0.04) and Child-Pugh B cirrhosis of the liver (odds ratio, 3.65; p = 0.04) remained statistically significant. The best estimates of the NTCP parameters were n = 0.35, m = 0.39, and TD 50(1) = 49.4 Gy. The n, m, TD 50(1) specifically estimated from the HBV carriers was 0.26, 0.40, and 50.0 Gy, respectively, compared with 0.86, 0.31, and 46.1 Gy, respectively, for non-carrier patients. Conclusion: Hepatocellular carcinoma patients who were HBV carriers or had Child-Pugh B cirrhosis presented with a statistically significantly greater susceptibility to RILD after 3D-CRT.

Original languageEnglish
Pages (from-to)1502-1509
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume60
Issue number5
DOIs
Publication statusPublished - Dec 1 2004
Externally publishedYes

Fingerprint

liver
Liver Diseases
Hepatocellular Carcinoma
radiation therapy
Radiotherapy
cancer
Radiation
hepatitis
magnetic permeability
Hepatitis B virus
viruses
radiation
Liver
dosage
Multivariate Analysis
Odds Ratio
Conformal Radiotherapy
phosphatases
Transaminases
logistics

Keywords

  • Hepatitis B virus carrier
  • Hepatocellular carcinoma
  • Normal tissue complication probability
  • Radiation-induced liver disease

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. / Cheng, Jason Chia Hsien; Wu, Jian Kuen; Lee, Patricia Chiao Tzu; Liu, Hua Shan; Jian, James Jer Min; Lin, Yu Mong; Sung, Juei Low; Jan, Gwo Jen.

In: International Journal of Radiation Oncology Biology Physics, Vol. 60, No. 5, 01.12.2004, p. 1502-1509.

Research output: Contribution to journalArticle

Cheng, Jason Chia Hsien ; Wu, Jian Kuen ; Lee, Patricia Chiao Tzu ; Liu, Hua Shan ; Jian, James Jer Min ; Lin, Yu Mong ; Sung, Juei Low ; Jan, Gwo Jen. / Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. In: International Journal of Radiation Oncology Biology Physics. 2004 ; Vol. 60, No. 5. pp. 1502-1509.
@article{ab03f94c148f4836a742d515fe973729,
title = "Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease",
abstract = "Purpose: To identify the factors associated with radiation-induced liver disease (RILD) and to describe the difference in normal tissue complication probability (NTCP) between subgroups of hepatocellular carcinoma patients undergoing three-dimensional conformal radiotherapy (3D-CRT). Methods and Materials: A total of 89 hepatocellular carcinoma patients who completed 3D-CRT for local hepatic tumors were included. The average isocenter dose was 49.9 ± 6.2 Gy. Logistic regression analysis was used for the association between statistically significant factors and RILD (defined as Grade 3 or 4 hepatic toxicity of elevated transaminases or alkaline phosphatase within 4 months of completing 3D-CRT) in multivariate analysis. Maximal likelihood analysis was conducted to obtain the best estimates of the NTCP model parameters. Results: Of the 89 patients, 17 developed RILD. In univariate analysis, hepatitis B virus (HBV)-positive status and the mean radiation dose to the liver were the two factors significantly associated with the development of RILD. Of the 65 patients who were HBV carriers, 16 had RILD compared with 1 of 24 non-carrier patients (p = 0.03). The mean radiation dose to liver was significantly greater in patients with RILD (22.9 vs. 19.0 Gy, p = 0.05). On multivariate analysis, HBV carrier status (odds ratio, 9.26; p = 0.04) and Child-Pugh B cirrhosis of the liver (odds ratio, 3.65; p = 0.04) remained statistically significant. The best estimates of the NTCP parameters were n = 0.35, m = 0.39, and TD 50(1) = 49.4 Gy. The n, m, TD 50(1) specifically estimated from the HBV carriers was 0.26, 0.40, and 50.0 Gy, respectively, compared with 0.86, 0.31, and 46.1 Gy, respectively, for non-carrier patients. Conclusion: Hepatocellular carcinoma patients who were HBV carriers or had Child-Pugh B cirrhosis presented with a statistically significantly greater susceptibility to RILD after 3D-CRT.",
keywords = "Hepatitis B virus carrier, Hepatocellular carcinoma, Normal tissue complication probability, Radiation-induced liver disease",
author = "Cheng, {Jason Chia Hsien} and Wu, {Jian Kuen} and Lee, {Patricia Chiao Tzu} and Liu, {Hua Shan} and Jian, {James Jer Min} and Lin, {Yu Mong} and Sung, {Juei Low} and Jan, {Gwo Jen}",
year = "2004",
month = "12",
day = "1",
doi = "10.1016/j.ijrobp.2004.05.048",
language = "English",
volume = "60",
pages = "1502--1509",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease

AU - Cheng, Jason Chia Hsien

AU - Wu, Jian Kuen

AU - Lee, Patricia Chiao Tzu

AU - Liu, Hua Shan

AU - Jian, James Jer Min

AU - Lin, Yu Mong

AU - Sung, Juei Low

AU - Jan, Gwo Jen

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Purpose: To identify the factors associated with radiation-induced liver disease (RILD) and to describe the difference in normal tissue complication probability (NTCP) between subgroups of hepatocellular carcinoma patients undergoing three-dimensional conformal radiotherapy (3D-CRT). Methods and Materials: A total of 89 hepatocellular carcinoma patients who completed 3D-CRT for local hepatic tumors were included. The average isocenter dose was 49.9 ± 6.2 Gy. Logistic regression analysis was used for the association between statistically significant factors and RILD (defined as Grade 3 or 4 hepatic toxicity of elevated transaminases or alkaline phosphatase within 4 months of completing 3D-CRT) in multivariate analysis. Maximal likelihood analysis was conducted to obtain the best estimates of the NTCP model parameters. Results: Of the 89 patients, 17 developed RILD. In univariate analysis, hepatitis B virus (HBV)-positive status and the mean radiation dose to the liver were the two factors significantly associated with the development of RILD. Of the 65 patients who were HBV carriers, 16 had RILD compared with 1 of 24 non-carrier patients (p = 0.03). The mean radiation dose to liver was significantly greater in patients with RILD (22.9 vs. 19.0 Gy, p = 0.05). On multivariate analysis, HBV carrier status (odds ratio, 9.26; p = 0.04) and Child-Pugh B cirrhosis of the liver (odds ratio, 3.65; p = 0.04) remained statistically significant. The best estimates of the NTCP parameters were n = 0.35, m = 0.39, and TD 50(1) = 49.4 Gy. The n, m, TD 50(1) specifically estimated from the HBV carriers was 0.26, 0.40, and 50.0 Gy, respectively, compared with 0.86, 0.31, and 46.1 Gy, respectively, for non-carrier patients. Conclusion: Hepatocellular carcinoma patients who were HBV carriers or had Child-Pugh B cirrhosis presented with a statistically significantly greater susceptibility to RILD after 3D-CRT.

AB - Purpose: To identify the factors associated with radiation-induced liver disease (RILD) and to describe the difference in normal tissue complication probability (NTCP) between subgroups of hepatocellular carcinoma patients undergoing three-dimensional conformal radiotherapy (3D-CRT). Methods and Materials: A total of 89 hepatocellular carcinoma patients who completed 3D-CRT for local hepatic tumors were included. The average isocenter dose was 49.9 ± 6.2 Gy. Logistic regression analysis was used for the association between statistically significant factors and RILD (defined as Grade 3 or 4 hepatic toxicity of elevated transaminases or alkaline phosphatase within 4 months of completing 3D-CRT) in multivariate analysis. Maximal likelihood analysis was conducted to obtain the best estimates of the NTCP model parameters. Results: Of the 89 patients, 17 developed RILD. In univariate analysis, hepatitis B virus (HBV)-positive status and the mean radiation dose to the liver were the two factors significantly associated with the development of RILD. Of the 65 patients who were HBV carriers, 16 had RILD compared with 1 of 24 non-carrier patients (p = 0.03). The mean radiation dose to liver was significantly greater in patients with RILD (22.9 vs. 19.0 Gy, p = 0.05). On multivariate analysis, HBV carrier status (odds ratio, 9.26; p = 0.04) and Child-Pugh B cirrhosis of the liver (odds ratio, 3.65; p = 0.04) remained statistically significant. The best estimates of the NTCP parameters were n = 0.35, m = 0.39, and TD 50(1) = 49.4 Gy. The n, m, TD 50(1) specifically estimated from the HBV carriers was 0.26, 0.40, and 50.0 Gy, respectively, compared with 0.86, 0.31, and 46.1 Gy, respectively, for non-carrier patients. Conclusion: Hepatocellular carcinoma patients who were HBV carriers or had Child-Pugh B cirrhosis presented with a statistically significantly greater susceptibility to RILD after 3D-CRT.

KW - Hepatitis B virus carrier

KW - Hepatocellular carcinoma

KW - Normal tissue complication probability

KW - Radiation-induced liver disease

UR - http://www.scopus.com/inward/record.url?scp=10044259730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044259730&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2004.05.048

DO - 10.1016/j.ijrobp.2004.05.048

M3 - Article

VL - 60

SP - 1502

EP - 1509

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -